Breaking News, Promotions & Moves

Aldagen, Inc.

Lyle A. Hohnke, Ph.D. has been appointed chief executive officer of Aldagen, Inc.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lyle A. Hohnke, Ph.D. has been appointed chief executive officer of Aldagen, Inc. Dr. Hohnke has more than 35 years of health care industry experience and has served on Aldagen’s board of directors since 2008. He succeeds Tom Amick. “We appreciate the guidance Tom has given Aldagen over the years, and thank him for his many contributions that have brought the company to its current stage of development,” said Richard Kent, M.D., chairman of Aldagen. “Lyle’s invol...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters